Pfizer (PFIZER.NS) Osake Kurssi
Pfizer Kurssi
Liikevaihto on kasvanut 7,0 % vuodessa viimeisten 19 vuoden aikana 25,20 Mrd. INR:een. Osakekohtainen tulos on kasvanut 10,6 % vuodessa viimeisten 19 vuoden aikana. Pfizern nettomarginaali on nyt 28,7 %, noussut 23,5 %:sta muutama vuosi sitten. Pfizern osinkotuotto on tällä hetkellä noin 3,34 %. Jakosuhde on noin 37 % tuloksesta. Osinko on kasvanut 9,7 % vuodessa viimeisten 19 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 6 222,00 INR, eli yli nykyhintaa 59,8 %. 8 analyytikosta 5 suosittaa ostoa — kokonaiskonsensus on Osta.
Pfizer osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Pfizer liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Pfizer -osakkeesta
The business model of Pfizer Ltd revolves around pharmaceutical research, development, manufacturing, and sales. As a leading global biopharmaceutical company, Pfizer focuses on discovering breakthrough medicines and vaccines for various health conditions. With a diverse portfolio, Pfizer aims to improve patient lives and promote better health outcomes by investing in innovative research and development. Through strategic partnerships and collaborations, Pfizer strives to advance healthcare solutions while maintaining a strong commitment to delivering quality products. By upholding high standards of scientific integrity and ethical business practices, Pfizer continues to contribute to the well-being of individuals worldwide.
Pfizer Ltd is primarily active in the pharmaceutical industry. Its core business focuses on the research, development, manufacture, and sale of a wide range of pharmaceutical products. Pfizer Ltd is a renowned global pharmaceutical company, known for its breakthrough medicines and innovative therapies across various therapeutic areas. With a strong presence in the healthcare sector, Pfizer Ltd strives to enhance and improve the well-being of individuals worldwide.
The main competitors of Pfizer Ltd in the market include pharmaceutical companies such as Johnson & Johnson, Merck & Co., GlaxoSmithKline, and Novartis.
Pfizer Ltd. is a renowned pharmaceutical company with a rich history and background. Founded in 1849, Pfizer has evolved into a leading global player in the healthcare industry. With headquarters in the United States, the company has expanded its reach worldwide, including operations in India through Pfizer Ltd. Pfizer Ltd. is committed to discovering, developing, and manufacturing innovative medicines, vaccines, and consumer healthcare products. The company's relentless pursuit of medical advancements and dedication to improving people's lives has earned Pfizer Ltd. a strong reputation and recognition as a trusted name in the pharmaceutical sector.
Pfizer Ltd, a renowned pharmaceutical company, has achieved several significant milestones over the years. Notably, Pfizer is credited with the development of life-saving drugs like Viagra, Lipitor, and Zoloft, which have had a tremendous impact on global healthcare. Pfizer's contributions in the fields of immunology, oncology, and cardiology have not gone unnoticed, establishing the company as a leader in medical advancements. Pfizer's commitment to research and innovation has resulted in groundbreaking treatments, ensuring better clinical outcomes for patients worldwide. This dedication to excellence and their bold pursuit of scientific breakthroughs have made Pfizer Ltd a trusted and influential player in the pharmaceutical industry.
Pfizer Ltd, a leading pharmaceutical company, has a prominent presence in various countries and regions globally. The company operates in several key markets, including the United States, Europe, Asia-Pacific, Latin America, and Africa. With its headquarters in New York, Pfizer Ltd has established a strong foothold in the United States, utilizing its extensive network for research, development, and distribution of innovative healthcare solutions. Additionally, Pfizer Ltd's operations span across Europe, where it operates in numerous countries, catering to diverse healthcare needs. Further, the company's presence extends to the Asia-Pacific region, Latin America, and Africa, emphasizing its commitment to addressing global health challenges effectively.
Pfizer Ltd represents a set of core values and a strong corporate philosophy. As a renowned pharmaceutical company, Pfizer Ltd is committed to innovation and scientific advancement in the healthcare industry. The company believes in providing high-quality and safe medications to improve patient outcomes. Pfizer Ltd also emphasizes integrity, ethical practices, and transparency in all aspects of its operations. With a dedication to research and development, Pfizer Ltd aims to discover and deliver life-saving and life-enhancing therapies for people worldwide. This commitment, along with a customer-centric approach, makes Pfizer Ltd a trusted name in the pharmaceutical sector.
Analyytikot asettavat tällä hetkellä Pfizer-osakkeelle keskimääräisen tavoitehinnan 6 389,08 INR (mediaani: 6 222,00 INR), mikä merkitsee +63,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 8 analyytikkoarvioon.
9 analyytikkoa arvioi tällä hetkellä Pfizer-osaketta: 6 suosittaa ostoa, 3 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla Pfizer-osake noteerataan hintaan 37,38 EUR (3 893,30 INR).
Pfizer-osake (PFIZER.NS) on listattuna 2 pörssissä, muun muassa: NSE (Indien) (PFIZER.NS).
Pfizer Ltd is a pharmaceutical company that focuses on the research, development, and marketing of products for the prevention and treatment of diseases. It has a global customer base and operates in various medical fields such as oncology, immunology, neurology, and infectious diseases. The company offers a wide range of medications, from well-established drugs to new therapies and biotechnological products. Its business model is centered on growth and profitability, with investments in research and development to remain competitive. Pfizer Ltd is organized into different divisions, including oncology, infectious diseases, immunology, and neurology, and also engages in the development of biotechnology products. Its products are marketed globally through pharmaceutical distribution channels. Overall, Pfizer Ltd strives to improve the health of patients worldwide through the development and marketing of innovative therapies.
liikevaihto Pfizer on 25,20 Mrd. INR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Pfizer on 7,22 Mrd. INR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Pfizer:n hinta-voitto-suhde (P/E) on tällä hetkellä 24,66. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Pfizer-osakkeen arvostusta.
Pfizer:n hinta-myynti-suhde (P/S) on tällä hetkellä 7,07. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Pfizer-osakkeen arvostuskennuslukuna.
Pfizer:n Eulpool-laatuscore on 5/10.
Pfizer:n ISIN on INE182A01018. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Pfizer:n ticker on PFIZER.NS. Tämä pörssinoteeraus käytetään Pfizer-osakkeiden kauppaan pörssissä.
Pfizer osake
Pfizer vertaisryhmä
Pfizer Ticker
Pfizer FIGI
Kaikki tunnusluvut ja syvällinen analyysi Pfizer:sta
Meidän osakeanalyysimme Pfizer-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Pfizer:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: